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Aberrant organ development is associated with awide spectrum of disorders, from schizophrenia to
congenital heart disease, but systems-level insight into the underlying processes is very limited.
Using heart morphogenesis as general model for dissecting the functional architecture of organ
development, we combined detailed phenotype information from deleterious mutations in 255
genes with high-confidence experimental interactome data, and coupled the results to thorough
experimental validation. Hereby, we made the first systematic analysis of spatio-temporal protein
networks driving many stages of a developing organ identifying several novel signaling modules.
Our results show that organ development relies on surprisingly few, extensively recycled, protein
modules that integrate into complex higher-order networks. This design allows the formation of a
complicated organ using simple building blocks, and suggests howmutations in the same genes can
lead to diverse phenotypes. We observe a striking temporal correlation between organ complexity
and the number of discrete functional modules coordinating morphogenesis. Our analysis
elucidates the organization and composition of spatio-temporal protein networks that drive the
formation of organs, which in the future may lay the foundation of novel approaches in treatments,
diagnostics, and regenerative medicine.
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Introduction
Insight into the biology of molecular networks driving organ
development is an important and emerging field as aberrations in
these systems underlie a wide spectrum of highly polygenic
human disorders, ranging from schizophrenia (Walsh et al, 2008)
to congenital heart disease (CHD) (Bruneau, 2008).Understanding
the functional architecture of networks that orchestrate the
development of organs may also lay the foundation of novel
approaches in regenerative medicine, because manipulation of
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these systems will be necessary for the success of tissue-
engineering technologies and stem cell therapy (Chien et al, 2008).
We used heart development and CHD as a general model for
dissecting the functional protein networks underlying a
developing organ and its related, genetically complex, human
phenotypes. The heart is particularly suitable for such an
analysis, because it is among the most studied of all organs, it
is the organmost susceptible to disease, and its developmental
processes and genes are extraordinarily conserved enabling
straight forward integration of data between humans and
model organisms (Olson, 2004; Srivastava, 2006).
Genetic studies in humans and model organisms have
identified hundreds of genes involved in heart development. In
mice, phenotypes caused by targeted mutations can be
organized into hierarchical morphological subgroups, which
point at the spatio-temporal function of the disrupted genes.
These results have led to a hypothesis suggesting that during
organ development, autonomous anatomical substructures are
coordinated by discrete protein complexes or pathways (i.e.
functional modules) integrating into higher-order functional
networks, and that evolutionary newer anatomical structures
might recycle parts of the networks used in more ancient
structures (Fishman and Olson, 1997). Although transcription
factors have been identified as central players in these
processes (Kornberg and Tabata, 1993; Basson et al, 1997;
Fishman and Olson, 1997; Schott et al, 1998; Weatherbee et al,
1998; Benson et al, 1999; Gaudet and Mango, 2002; Garg et al,
2003; Pourquie, 2003; Gaudet et al, 2004; Srivastava, 2006), we
currently lack overviews of how most genes integrate into
functional modules and networks during the different devel-
opmental stages. Our lack of understanding of this biological
architecture is exemplified by the knowledge that genetic
factors contribute significantly to CHD (Bruneau, 2008), but
o5% of CHD patients have mutations within the few
identified causal human genes, suggesting that many genetic
principles of the molecular networks driving heart develop-
ment remain to be understood.
Results and discussion
First, we manually curated a set of 255 cardiac developmental
(CD) genes, in which targeted mutation leads to heart
phenotypes in mouse models, from the Mouse Genome
Database ver. 3.44 (Bult et al, 2008). We used the Inparanoid
orthology database (O’Brien et al, 2005) to find the ortholo-
gous 255 human genes, and then identified their correspond-
ing human proteins. We used InParanoid as this method,
several times, has been shown to be superior to other methods
for mapping functional orthologs (Hulsen et al, 2006; Chen
et al, 2007). We refer to this set of human proteins as CD
proteins. The 255 proteins are stratified into a total of 19
morphological subgroups reflecting the specific phenotype
associated with their mutation (Supplementary Table S1),
which can be used as an indicator for the spatio-temporal
function of the individual genes. For each of the 19 sets of
proteins, we constructed functional networks (Supplementary
Figures S1–S4) using their interaction patterns in refined
experimental proteomics data (see Materials and methods),
and indeed several novel modules not previously associated
with heart development emerged from our analysis (see
below). Randomization tests of the resulting networks show
that 18 of the 19 gene sets significantly interact at the protein
level after adjustment for multiple testing using a Bonferroni
correction (seeMaterials andmethods; Supplementary Figures
S1–S4), indicating that the genes involved in each develop-
mental stage (and its corresponding specific phenotype) have
a strong tendency to directly interact at the protein level, or are
part of connected pathways. In total, the resulting interaction
networks consist of 629 unique proteins, have both time and
tissue resolution, and describe awide variety of developmental
stages and anatomical structures in the developing heart.
These data represent a new framework for the study of
organ development at the systems level, and they extend
considerably our understanding of the highly polygenic
nature of organ developmental processes, which has been
shown previously at the level of gene expression (Maduro and
Rothman, 2002).
We manually annotated the functional clusters in the
networks by literature curation. We chose manual literature
curation over automated gene ontology analyses, to exploit the
considerable experience and expertise in our group on
developmental programs. This analysis revealed several
functional modules, which are novel in relation to heart
development, including focal adhesion signaling modules and
a module of unknown function, which include Sorting nexin 9
(SNX9; Supplementary Information; Supplementary Figures
S2C and S3A). The quality of the data was confirmed by the
existence of many known functional modules in the networks
(e.g. NOTCH signaling in the development of the ventricular
trabeculae; Grego-Bessa et al, 2007). Examples of four
networks are shown in Figure 1; the proteins involved in four
phenotypes and their interaction partners fall into distinct
modules, represented as highly interconnected subclusters in
the networks. For example, the data show that WNT,
semaphorin, FGF/PDGFR, BMP/TGFbeta, and retinoic acid
signaling are involved in the development of the outflow tract
and suggest that extensive communication takes place within
and between modules.
To get insight into how the modularity of heart development
is organized across spatio-temporal morphological stages, we
created module maps of the different networks and grouped
them according to temporal development (i.e. early, inter-
mediate, and late developmental stages of organogenesis;
Figure 2). Here, the modular design of the functional networks
becomes clear across developmental stages and anatomical
structures. Surprisingly, although the networks in some
instances contain hundreds of proteins, they consist of
relatively few protein modules that are extensively recycled
across developmental stages (Figure 2A and B). Moreover,
each network consists of a combinatorial unique module
pattern. Although modularity is known to be a core feature
of the organization of organisms (Wagner et al, 2007), to our
knowledge, this concept has not been shown at the level
of protein networks in organ development before. This
organizational concept allows for the formation of a very
complex organ using relatively simple building blocks and
suggests how mutations in the same genes and modules can
lead to very diverse phenotypes. For example, NOTCH
signaling modules are present in the networks representing
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atrial septal defects (ASD; Supplementary Figure S2A) and
double outlet right ventricle (DORV; Supplementary Figure
S3C) in line with the observation that mutations in NOTCH1
may lead to ASDs in one individual, and DORV in another
(Garg et al, 2005).
Development of the human heart starts B2 weeks after
fertilization, with the formation of the cardiac crescent and the
subsequent formation and looping of the primitive heart tube.
At this stage, the heart is an anatomically simple structure
associated with the ‘early phenotype’ networks in Figure 2.
Looping is followed by extensive tissue remodeling, which
includes septation of the atrium and ventricles, and develop-
ment of trabeculae within the ventricles. Defects at this stage
results in ‘intermediate phenotypes.’ The last stages of heart
development include construction of the heart valves and
separation of the outflow tract, as determined by ‘late
phenotypes.’ Throughout this transformation, the organ, along
with the embryo, becomes an anatomically much more
elaborate structure (Srivastava, 2006), which remarkably is
mirrored in the complexity of the functional networks we have
identified as drivers of these processes.
We have quantified network complexity based on (1) the
number of distinct functional modules present in each network
and (2) the total amount of proteins in each network. The
amount of modules in networks associated with ‘early
phenotypes’ is on average 2.5, which increases to an average
of 5.8 for ‘late phenotypes’ (Figure 2C; Spearman r¼0.76,
P¼0.010). A similar observation can be made for the total
amount of proteins in each network that increases from an
average of 42 to an average of 119 (Figure 2D; Spearman
r¼0.72, P¼0.016). Although the stages of heart development
are broadly defined, there is a clear trend across all networks
for later phenotypes to be associated with more complex and
functionally diverse networks.
Thus, our analysis of the networks strongly suggest that
increased morphological complexity of the heart is correlated
Figure 1 Examples of four functional networks driving the development of different anatomical structures in the human heart. These four networks constructed by
analyzing the interaction patterns of four different sets of cardiac development (CD) proteins corresponding to the morphological groups ‘atrial septal defects,’ ‘abnormal
atrioventricular valve morphology,’ ‘abnormal myocardial trabeculae morphology,’ and ‘abnormal outflow tract development’ (Supplementary Table S1). CD proteins from
the relevant groups are shown in orange and their interaction partners are shown in gray. Functional modules annotated by literature curation are indicated with a colored
background. High-resolution figures (including protein names) can be seen in Supplementary Figures S2A, S2C, S2D, and S3B, respectively. Centrally in the figure is a
haematoxylin-eosin stained frontal section of the heart from a 37-day human embryo, where tissues affected by the four networks are marked; AS (developing atrial
septum), EC (endocardial cushions, which are anatomical precursors to the atrioventricular valves), VT (developing ventricular trabeculae), and OFT (developing outflow
tract). The entire set of 19 networks is shown in detail in Supplementary Figures S1–S4, and can be downloaded from http://www.cbs.dtu.dk/suppl/dgf/.
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with increased signaling complexity at the molecular level,
which support a model predicting that the four-chambered
heart has evolved by addition of new autonomous anatomical
structures (Moorman and Christoffels, 2003; Olson, 2006).
Analysis of functional data at the systems level suggests that
this evolution in part relies on recycling and shuffling of
existing functional modules, to create combinatorial unique
functional networks that drive the formation of new anatomical
Figure 2 An overview of the modular organization of heart development. (A) Protein interaction networks are plotted at the resolution of functional modules. Each
module is color coded according to functional assignment as determined by literature curation. The amount of proteins in each module is proportional to the area of its
corresponding node. Edges indicate direct (lines) or indirect (dotted lines) interactions between proteins from the relevant modules. (B) Recycling of functional modules
during heart development. The bars represent functional modules and recycling is indicated by arrows. The bars follow the color code of (A) and the height of the bars
represent the number of proteins in each module, as shown on the y axis (left). (C–E) Correlations between anatomical, modular, and transcriptional complexity in organ
developmental networks. We plotted network complexity along an axis of increasing anatomical complexity as defined by the early, late, and intermediate phenotypes
(C, D), and observe a significant correlation. Also, modular and transcriptional complexity correlate significantly during the traversing of organ developmental programs
and stages (E). In a given network, module content is the amount of modules, protein content is the amount of proteins, and transcriptional content is the amount of
proteins directly involved in transcriptional regulation.
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structures. Furthermore, our results mirror the findings of
evolution modeling and algorithms, which show that mod-
ularity in networks can spontaneously arise under changing
environments (Lipson et al, 2002; Kashtan and Alon, 2005), a
principle that allows for rapid organism adaptation to new
demands (Kashtan and Alon, 2005). Importantly, we couple
these findings to the anatomical development of organs and
together these studies give insight into the forces that advance
structural simplicity in biological networks underlying organ
development.
Formation of organs depends on highly conserved sets of
transcription factors (Satou and Satoh, 2006) of which spatio-
temporal regulation is critical to achieve correct patterning
(Pourquie, 2003). During development, series of transcription
factors function hierarchically to regulate specific develop-
mental programs (Kim et al, 2001; Maduro and Rothman,
2002; Skeath and Thor, 2003). These observations raise the
question of how transcriptional programs are linked to the
timing of developmental processes and the relationship
between the transcriptional programs, cellular networks,
diseases, and the developing organ.
GATA4, NKX2-5, and TBX5 are known to be involved in
many stages of heart development, and defects in these
genes have been established as the cause of familial CHD
(Basson et al, 1997; Schott et al, 1998; Garg et al, 2003).
As expected, we observe these transcription factors partici-
pating in most of the networks and across almost all stages
of heart development, stressing their importance (Supple-
mentary Figures S1–S4). In addition to GATA4, NKX2-5, and
TBX5, the networks also contain a large amount of other
proteins directly involved in transcriptional control either
as transcription factors, or by participating in transcription
initiation complexes and networks (Figure 2; Supplementary
Figures S1–S4).
Two transcriptional concepts have been observed in organ
development. Some regulators are only active for a brief period
of time and usually produce a uniform response in the
expressing cells (Kornberg and Tabata, 1993; Maduro and
Rothman, 2002; Skeath and Thor, 2003). Other regulators such
as GATA4, NKX2-5, and TBX5 are continuously expressed, but
activate different sets of genes at different developmental
stages, suggesting they are parts of more heterogeneous and
complex transcriptional programs (Weatherbee et al, 1998;
Bergstrom et al, 2002; Gaudet and Mango, 2002; Gaudet et al,
2004). The latter type of regulators exert their specific function
by exploiting promoter affinity gradients, and through
complicated patterns of promoter elements that scaffold sets
of transcriptional proteins (Gaudet and Mango, 2002; Gaudet
et al, 2004). Our data show that GATA4, NKX2-5, and TBX5
participate in most of the transcriptional modules throughout
heart development as expected (Supplementary Figures S1–S4),
but interestingly, the modules vary widely in complexity and in
the specific composition of the participating proteins. Thus, on
the level of transcriptional protein networks, we observe
combinatorial regulation, which provides the organism with a
high degree of flexibility for GATA4, NKX2-5, and TBX5, and
enables them to have a broad function during heart develop-
ment. This is consistent with the remarkable variability of
phenotypic outcome that can be the result of mutations in each
of these genes.
Interestingly, the amount of transcriptional proteins in the
networks increases from an average of 11 in the networks
associated with ‘early phenotypes,’ to 32 in the networks
associated with ‘late phenotypes.’ Moreover, there is a
significant correlation between the amount of modules in
each network and the amount of proteins directly involved in
transcriptional control in the same networks (Figure 2E;
Spearman r¼0.69, P¼0.035). Thus, our results show a direct
relationship between anatomical, modular, and transcriptional
complexity during the traversing of organ developmental
programs and support the concept of combinatorial regulation
at the protein level.
To experimentally test the biological accuracy of the module
maps, we systematically identified 49 novel heart develop-
mental proteins from the modules (Supplementary Tables S2
and S3). These candidates were interacting significantly with
the CD set, but were not in the literature associated with heart
developmental processes (the procedure for scoring and
identifying the final 49 candidates is described in detail in
Supplementary Information and Supplementary Figures S5).
Twelve of these candidates were selected for immunohisto-
chemistry (IH) analyses to test whether they were expressed at
the time and place determined by the functional networks in
which they participate and the specific morphological groups
associated with those networks (the procedure and criteria for
choosing the tested proteins is described in detail in
Supplementary Information and Supplementary Figures S5
and S6). Immunohistochemical analyses were systematically
performed on a total of 382 tissue sections from 19 developing
human hearts in a blinded manner, and a semi-quantitative
measure for the expression level of each protein was
determined in at least six anatomical structures or tissues,
and across six developmental time points (Supplementary
Table S4; Supplementary Figures S7–S13).
For all 12 proteins, we see strong evidence of heart
developmental function (Supplementary Table S4). Impor-
tantly, 11 of the proteins (SNX9, DLL1 (DELTA), NOTCH3,
JAG2, PTGS2 (COX-2), CAV3, SRC, MAPK3 (ERK1), MAPK8
(JNK1), BMX, and PTK2B) are specifically expressed in the
anatomical structures associated with the morphological
grouping of the functional network in which they participate
(Supplementary Table S5 and Supplementary Figures S7–S13).
As a standardized estimate of the network-based prediction
signal, we calculated the precision of our predictions as the
true functional predictions among all functional predictions
(or the amount of true positives among all positives). Using a
conservative estimate of a true functional prediction, the
precision is 0.72 (Supplementary Information; Supplementary
Table S5), meaning that the morphological groups associated
networks in which a candidate emerges, correlate with the
candidates being specifically, and highly, expressed in relevant
tissues at relevant time points in 72% of the cases. For
example, SNX9, which is not associated with heart develop-
ment in the literature, emerges in several networks associated
with valve development (Supplementary Figures S2C and
S3A). We confirmed this function of SNX9 by observing that it
is highly expressed specifically in the cell populations driving
the development of the endocardial cushions, which are
anatomical precursors of the heart valves, and aortic valves
(AVs; Figure 3A–C). Analogously, DLL1 and PTGS2 are
Organ developmental networks and related disorders
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Figure 3 Examples of functional validations of candidates emerging from the networks. (A–F) The functional validations rely on a total of 382 tissue sections of which only a
very small subset (6/382 or o2%) are shown in this figure. (A) SNX9 is located in clusters of unknown function involved in the development of the cardiac valves
(Supplementary Figures S2C and S3A), which correlates with its specific expression in endothelial cells of the endocardial cushions (EC, precursors of heart valves) in a 9-week-
old human heart. Note that strong expression of SNX9 is confined to the endothelial cells lining the developing portion of the EC (section below (A)). (B) Toluidine blue staining of
hyaluronic acid, a marker for epithelial-mesenchymal transformation in the endocardial cushions correlates with the expression pattern of SNX9, hereby confirming its expression
specifically in the developing parts of the EC. (C) SNX9 expression in endothelial cells of the developing aortic valves (AVs) in a 9-week-old human heart. Strong expression is
shown in endothelial cells lining the valves and in cells within the valves. (D) DLL1 expression in the leading edge of septum primum (SP) in a 6-week-old human heart. DLL1 is
located in a NOTCH signaling cluster involved in the development of the atrial septum (Supplementary Figure S2A). Note the stronger expression in the migrating and developing
part of the SP (arrows) compared with endothelial cells lining the inner surface of the atrial wall (asterisk). (E, F) Expression in cardiomyocytes of the ventricle and atrium of
PTGS2 in an 18-week-old human heart. PTGS2 is located in several clusters involved in myocardial growth and organization (Supplementary Figure S4A–E). Note the stronger
expression of PTGS2 in the atrium (At) compared with the ventricle (Vt). (G–L) Validating a larger set of 49 candidates by real-time quantitative RT–PCR. (G) The gene
expression level of the candidate genes and 29 control genes were measured in two hearts collected from embryos at ages 46 days and 67 days, respectively. Controls were
genes corresponding to randomly chosen proteins that did not significantly interact with the 255 CD proteins, but were represented in our interaction data set. The data
distribution is displayed by a box-and-whisker plot. A single outlier data point in the control group is shown with an asterisk. (H) Heatmap showing the relative level of gene
expression of 18 representative candidates (level at day 40¼1). The gene expression level of each of the 18 candidate genes was analyzed in hearts collected from 12 human
embryos or fetuses of the indicated stages of development (between days 40–68 post-fertilization). The data were sorted in four groups according to expression pattern of the
genes using hierarchical clustering. Statistical significant correlation between expression value and days post-fertilization is marked with an asterisk. (I–L) Representative plots of
gene expression within the four groups. A trend line representing the average value of the data in four groups of three data points is shown as a smoothed line. Expression levels
were measured by QPCR, and the data were normalized using the average value of six housekeeping genes (GAPDH, COX4A, B2M, ATP6A, HPRT, and RPL13).
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predicted to be involved in the development of the atrial
septum (Supplementary Figure S2A), and cardiac myocardium
(Supplementary Figure S4A–E), respectively. These predic-
tions are confirmed by their specific expression patterns in the
relevant structures of the developing heart at the correct
developmental time points (Figure 3D–F). For enlargements of
IH pictures, many more details, examples of antibody
specificity, and a more thorough discussion of the functional
roles of these candidates see Supplementary Information and
Supplementary Figures S7–S14.
To further validate the network data, we carried out
expression profiling of the larger set of 49 candidates across
different developmental stages using quantitative real-time
RT–PCR on RNA extracted from 14 embryonic human hearts
(Figure 3G–L). The candidates were significantly differentially
expressed during heart development, compared with a set of
controls (Figure 3G; Mann–Whitney (Wilcoxon) W test,
Po0.006; Supplementary Table S6), and significantly higher
expressed in heart tissues than random controls (P¼0.016;
Supplementary Figure S15; Supplementary Information). To
investigate this trend in more detail, we analyzed the relative
expression levels of a subset of the candidates in 12 additional
hearts at 12 different time points between 40 and 67 days
post-fertilization (Supplementary Table S7). This analysis
showed that half of the candidates were significantly
differentially expressed across these 12 time points further
supporting their function in human heart development (Figure
3H–L; Supplementary Table S7). Together with the IH results,
these data strongly establish the biological signal in our
network data, and the high accuracy of the module maps.
Conclusion
We present a framework for gaining new insights into the
systems biology of the protein networks driving organ
development and related polygenic human disease pheno-
types, exemplified here with heart development and CHD. Our
analysis is the first example of large-scale integration of
phenotypic data from targeted mice mutants with high-
confidence experimental proteomics data and represents the
most comprehensive characterization and analysis of the
functional protein networks underlying the development of an
organ system to date. A strength of our approach is that it
immediately puts new candidates in the functional context of
other, more well-characterized, network components.
We have shown that analysis of organ development at the
systems level can be used to discover new developmental
modules, gain insight into the evolution of organs, and
understand the biology of highly polygenic disorders asso-
ciated with aberrant organ development. A weakness of the
method is the lack of cellular resolution of the networks due to
use of macroscopic phenotypes as the starting point of the
analysis. However, the morphological subgroups associated
with the networks, and the IH data (which has the resolution of
individual cells), strongly suggests in which cell populations
the individual networks are active. The networks generated
here can be used as a community resource for addressing
major questions in developmental and cardiac biology, and we
havemade a database of the relevant network data available at
http://www.cbs.dtu.dk/suppl/dgf/.
In principle, the framework can be applied to any organ, to
widen our understanding of the functional architecture of
protein networks that drive the formation of organs. In
addition, they can facilitate the evolution of novel approaches
in regenerative medicine, because a thorough characterization
and understanding of the genes, proteins, pathways, and
concepts underlying organ developmental programs will be
necessary for the successful manipulation of these systems in
tissue-engineering technologies and stem cell therapy. Finally,
the networks can be used as a functional scaffold for
understanding combinatorial effects of gene–gene and gene–
environment interactions in complex heart phenotypes.
Materials and methods
Generating a functional network
A network is generated by determining the first- and second-order
interactions of CD proteins associated with a given morphological
subgroup in a human protein interaction network consisting of refined
experimental proteomics data. This network is described in high detail
in Lage et al (2007, 2008), and online (http://www.cbs.dtu.dk/suppl/
dgf/). The full network (InWeb 29) can be downloaded from (http://
www.cbs.dtu.dk/suppl/dgf/). Interactions of the CD proteins are
integrated into a network by always including direct interactions
between CD proteins, and only including indirect interactions
mediated through proteins with Q percent of its interactions to the
CD set. Various thresholds for Q are iteratively tested and value of Q for
the final network is chosen based on which value gives the optimal
network significance, this procedure is described in detail in Bergholdt
et al (2007) and D’Hertog et al (2007). The method for determining
network significances can be seen below. Detailed views of the
networks can be seen in Supplementary Figures S1–S4.
Determining network significances
The significance of each of the generated 19 networks was determined
by randomization testing as described in detail earlier (Bergholdt et al,
2007; D’Hertog et al, 2007). Specifically, for an input set of Ninput
proteins yielding an interaction network (connected component) with
G input proteins and T total proteins, a network score (NSinput) was
determined. This network score is the fraction of input proteins of all
proteins in the network (G/T). We then determined the significance of
the network score by empirically estimating the probability of
observing a similar or better network score in networks generated by
using 10 000 random input sets of size Ninput. The random gene sets
were chosen so the degree distribution of proteins in the random sets
approximate the input set. As each query generates a varying number
of networks (connected components) the probability estimates can be
calculated from the total amount of networks produced by all 10 000
randomizations that have a network score4NSinput. For this reason,
network P-values can be lower than the amount of random queries.
All network P-values can be seen in Supplementary Figures S1–S4
below the title of the network. To rule out the chance of functional bias
in the CD set, we analyzed the set for bias as discussed in
Supplementary Information.
Identifying candidates for IH and expression
analyses
A set of raw candidates were determined by querying all proteins in
our interaction network for the amount of interactions to the CD set
and determining the hypergeometric probability of this interaction
profile. Out of all proteins in the proteome, 49 novel candidates had a
significant interaction profile to the CD proteins after adjustment for
multiple testing (described in detail in Supplementary Information and
Supplementary Figure S5). We then used the functional networks
assigned to each morphological subgroup to determine the most likely
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developmental function of the candidates. This was done by
identifying the specific subnetworks to which the interactions of the
candidates were most significant (as described in Supplementary
Information and Supplementary Figure S6). In all, 12 of the 49
candidates were chosen for IH analysis based on the overlap between
morphological subgroups and the developmental stages present in our
panel of embryonic hearts available for validation experiments.
Human embryonic and fetal heart tissues
Human embryonic tissues were collected from legal abortions,
according to the Helsinki Declaration II, and their use was approved
by the local science ethics committee. Embryonic or fetal age was
based on measurement of crown-rump length. Immediately after
dissection, the samples were snap frozen in liquid nitrogen or treated
with RNA later according to the manufacturer’s instructions (Ambion,
Austin, TX). Samples for IH were dissected into appropriate tissue
blocks and fixed for 12–24h at 4 1C in either 10% neutral-buffered
formalin, 4% Formol-Calcium, Lillie’s or Bouin’s fixatives. The
specimens were dehydrated with graded alcohols, cleared in xylene
and paraffin embedded. Serial sections, 3–5mm thick, were cut in
transverse, sagittal or horizontal planes and placed on silanized slides.
Immunohistochemical analysis
Sections were deparaffinized and rehydrated in xylene followed by
a series of graded alcohols according to the established procedures.
The sections were treated with a fresh 0.5% solution of hydrogen
peroxide in methanol for 15min to quench endogenous peroxidase
and then rinsed in TRIS-buffered saline (TBS, 5mM Tris–HCl, 146mM
NaCl, pH 7.6). Non-specific binding was inhibited by incubation for
30min with blocking buffer (ChemMate antibody diluent S2022,
DakoCytomation, Glostrup, Denmark) at room temperature. The
sections were then incubated overnight at 41C with the primary
antibody in blocking buffer (ChemMate antibody diluent S2022,
DakoCytomation). The sections were washed with TBS and then
incubated for 30min with a peroxidase-labeled secondary antibody.
The sectionswerewashedwith TBS, followed by incubation for 10min
with 3,30-diamino-benzidine chromogen solution. Positive staining
was recognized as a brown color. The sections were dehydrated in
graded alcohols followed by xylene and coverslipped with DPX
mounting media. Non-immune rabbit IgG1 (X0936) was used as
negative control. Specificity of the antibodies were determined by their
ability to stain specific cell populations in the tissue sections (examples
are shown in Supplementary Figures S7–S12).
The following primary antibodies were used: anti-PTGS2 (35-8200,
Invitrogen), anti-MAPK8 (SC-6254, Santa Cruz Biotechnology, Santa
Cruz, CA), anti-CAV3 (610421, BD transduction laboratories, Franklin
Lakes, NJ), anti-MAPK3 (SC-7383, Santa Cruz Biotechnology), anti-
SRC (AT-7016, MBL International, Woborn, MA), anti-JAG2 (SC-8157,
Santa Cruz Biotechnology), anti-DLL1 (SC-9102, Santa Cruz Biotech-
nology), anti-NOTCH3 (SC-7474, Santa Cruz Biotechnology), anti-
NOTCH4 (SC-5594, Santa Cruz Biotechnology), anti-BMX (ab73887,
Abcam, Cambridge, UK), anti-PTK2B (ab78119, Abcam), anti-BMP4
(ab31165, Abcam ), Anti-EGFR (#2232, Cell Signaling Technology,
Boston, MA).
Real-time quantitative RT–PCR (QPCR)
We chose quantitative real-time quantitative RT–PCR for this analysis
because it is considered to be the most accurate and sensitive method
for detecting RNA differences also at very small amounts (Lang et al,
2009). Total RNA was isolated from tissues using TRIzol Reagent
(Invitrogen, Taastrup, Denmark) and cDNA synthesized with Super-
Script II (RNase H) reverse transcriptase (Invitrogen) according to the
manufacturer’s instructions. QPCR analysis was carried out on an ABI
7500 Fast real-time PCR system using a LightCycler FastStart DNA
MasterPLUS SYBR GreenI kit (Roche, Hvidovre, Denmark). Primer
sequences used for QPCR analysis are available on request. To exclude
that polymorphic gene expression between the individual developing
hearts could account for the observed differential expression trends
reported by QPCR, we also used polony multiplex analysis of gene
expression (Kim et al, 2007) to measure the expression of the 49
candidates in right ventricular outflow tract from TOF patients at the
time of primary surgical repair and left ventricle collected from
patients with either heart failure or diabetic cardiomyopathy. The
expression levels of the candidates were comparedwith the expression
levels of a different set of 49 randomly chosen controls after
normalizing both gene sets against gene expression in glioblastoma
tissue. Here, the heart developmental candidates were significantly
higher expressed in heart tissue than the controls (P¼0.016) (see
Supplementary Information and Supplementary Figure S13).
Supplementary information
Supplementary information is available at the Molecular Systems
Biology website (http://www.nature.com/msb).
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